(1S,4R)-4-Boc-aminocyclopent-2-enecarboxylic acid, 95.0%, 5g

2,4-Dichloro-7,8-dihydropyrido[4,3-d]pyrimidin-5(6H)-one, 97%, 100mg

(5-Chloro-2-methyl-1H-indol-3-yl)-acetic acid, 95.0%, 10g

2-Bromo-1-(2-hydroxyphenyl)ethanone, 95.0%, 1g

5-(Dimethylamino)naphthalene-1-sulfonic acid, 98%, 25g

1-OXA-8-AZASPIRO[4.5]DECAN-2-ONE, 95.0%, 1g

5-(2,2,2-Trifluoroacetyl)-2,3-dihydrobenzofuran, 97.0%, 250mg

Di(N-succinimidyl) 3,3'-Dithiodipropionate [Cross-linking Reagent]>97.0%(N)1g

Boîte anti-rayonnement SEKUROKA® Antibeta Screens, Maxi, 300 x 185 x 160 mm, 1 pièce

2-(2-oxobenzo[cd]indol-1(2H)-yl)propanoic acid, 95.0%, 1g

Ethyl 3-aminobutanoate, 95.0%, 25g

4-Hexyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene>98.0%(GC)5g

2-Amino-4-hydroxybenzothiazole, 95.0%, 250mg